Should you buy the dip on these ASX 200 stocks?

After yesterday's fall, are these stocks worth a buy?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) is off to a modest start in 2026. 

Australia's benchmark index is up roughly 1% since the start of the new year. 

Two ASX 200 stocks I have my eye on are ARB Corporation Ltd (ASX: ARB) and IperionX Ltd (ASX: IPX). 

These two companies have experienced very different starts to the year. 

However it appears both may be trading below fair value. 

Here's what experts are saying. 

An older woman gazes over the top of her glasses with a quizzical expression as if she is considering some information.

Image source: Getty Images

ARB Corporation Ltd (ASX: ARB)

This ASX 200 company is Australia's largest designer, manufacturer, and distributor of four-wheel-drive and light commercial vehicle accessories.

The company has carved a niche with aftermarket accessories including bull bars, suspension systems, differentials, and lighting.

Its stock price has tumbled more than 11% for the year to date. 

This week alone, the company has seen its share price fall 12% on the back of its half-year trading update.

It appears investors were heavily selling after the company reported Australian aftermarket sales declined 1.7%. 

The Motley Fool's Aaron Teboneras reported yesterday this result reflected softer demand for key vehicle models and ongoing fitting capacity constraints.

Perhaps even more concerning was that ARB expects to report underlying profit before tax of approximately $58 million for the half year. 

This represents a 16.3% decline compared with the prior year.

However, it wasn't all bad news. The company also reported export sales had increased 8.8%, with US market sales up 26.1%. 

This ASX 200 company is now trading close to its 52-week low, which could be an attractive entry point for value investors.

TradingView has an average one year price target of $41.34. 

This indicates more than 45% upside from yesterday's closing price. 

IperionX Ltd (ASX: IPX)

It has been a very different year for IperionX. 

The low carbon titanium developer has seen its share price soar almost 20% since the start of the year. 

This has been fuelled by key contract wins amidst the United States' push to strengthen the defence-related supply chains for critical materials.

Despite the emerging tailwinds, this ASX 200 stock still sits 20% below its 52-week high.

It also experienced a slight dip yesterday, dropping more than 2%. 

Analysts insights suggest it has the potential to keep rising. 

Back in December, broker Bell Potter said the company has the potential to disrupt the incumbent titanium supply chain through materially lowering production costs and manufacturing waste. 

The broker has a speculative buy recommendation along with a price target of $9.25. 

This indicates a further upside of 33.29% from yesterday's closing price. 

Meanwhile, TradingView estimates suggest the stock price could rise a further 37%. 

Motley Fool contributor Aaron Bell has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended ARB Corporation. The Motley Fool Australia has recommended ARB Corporation. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on 52-Week Lows

A man sitting at a computer is blown away by what he's seeing on the screen, hair and tie whooshing back as he screams argh in panic.
Bank Shares

NAB shares sink to 52-week low, are they in the buy zone?

This big four bank's shares are hitting a new low on Tuesday.

Read more »

a woman looks exhausted and overwhelmed as she slumps forward into her hand while looking at her laptop screen.
52-Week Lows

Are CSL and ResMed shares buys at 52-week lows?

These ASX healthcare shares may not regain investor confidence overnight, but I think they are worth studying while sentiment is…

Read more »

A senior couple discusses a share trade they are making on a laptop computer.
52-Week Lows

Are these oversold ASX shares too cheap to ignore?

These stocks could be bargain buys.

Read more »

Young businessman lost in depression on stairs.
52-Week Lows

Which of these shares hitting 52-week lows can bounce back?

Is there any potential for these struggling shares?

Read more »

Shot of a young businesswoman looking stressed out while working in an office.
52-Week Lows

Should investors buy low on these ASX shares hitting 52-week lows?

It could be time to scoop up the value.

Read more »

A woman sits on sofa pondering a question.
52-Week Lows

Down 40%: Why this ASX 200 stock could be a top buy at a 52-week low

This company has been hit by weak sentiment, but the valuation and forecast dividend yield now look much more interesting.

Read more »

Woman with a scared look has hands on her face.
52-Week Lows

Why did this ASX 300 stock just crash 15% to a 52-week low?

This online retailer's shares are under the pump again today.

Read more »

Woman on her laptop thinking to herself.
52-Week Lows

2 big-name ASX 200 shares at 52-week lows that I'd buy and hold

These companies are facing very different challenges, but both still have long-term qualities I would be willing to back.

Read more »